Jingfang Ju

17.5k total citations
123 papers, 7.2k citations indexed

About

Jingfang Ju is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jingfang Ju has authored 123 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 73 papers in Cancer Research and 37 papers in Oncology. Recurrent topics in Jingfang Ju's work include MicroRNA in disease regulation (61 papers), Cancer-related molecular mechanisms research (44 papers) and Circular RNAs in diseases (33 papers). Jingfang Ju is often cited by papers focused on MicroRNA in disease regulation (61 papers), Cancer-related molecular mechanisms research (44 papers) and Circular RNAs in diseases (33 papers). Jingfang Ju collaborates with scholars based in United States, China and Japan. Jingfang Ju's co-authors include Yaguang Xi, Kenji Kudo, Øystein Fodstad, Andrew Fesler, Bo Song, Mihriban Karaayvaz, Elaine Gavin, Go Nakajima, A. Formentini and Haiyan Zhai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Advanced Materials.

In The Last Decade

Jingfang Ju

121 papers receiving 7.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingfang Ju United States 45 5.5k 4.3k 1.6k 448 392 123 7.2k
Jinjun Li China 45 4.8k 0.9× 3.1k 0.7× 1.7k 1.1× 553 1.2× 520 1.3× 137 7.0k
Shijie Sheng United States 40 3.7k 0.7× 2.9k 0.7× 1.6k 1.0× 529 1.2× 391 1.0× 85 6.0k
Kumaravel Somasundaram India 44 4.5k 0.8× 1.9k 0.4× 2.0k 1.3× 325 0.7× 451 1.2× 107 6.5k
Andreas G. Bader United States 30 7.2k 1.3× 5.3k 1.2× 1.6k 1.0× 792 1.8× 616 1.6× 58 8.9k
David J. Wong United States 22 5.7k 1.0× 4.3k 1.0× 1.1k 0.7× 391 0.9× 688 1.8× 28 7.7k
Ming Yao China 52 6.3k 1.2× 4.3k 1.0× 1.9k 1.2× 771 1.7× 668 1.7× 139 8.8k
Yang Wang China 45 8.1k 1.5× 3.8k 0.9× 793 0.5× 430 1.0× 451 1.2× 225 9.5k
Fangyu Zhao China 42 3.7k 0.7× 2.8k 0.7× 1.3k 0.8× 633 1.4× 571 1.5× 124 5.5k
Yin‐Yuan Mo United States 43 6.6k 1.2× 5.5k 1.3× 1.0k 0.7× 545 1.2× 388 1.0× 92 8.0k
Songqing Fan China 41 3.8k 0.7× 1.7k 0.4× 1.6k 1.0× 647 1.4× 599 1.5× 185 5.2k

Countries citing papers authored by Jingfang Ju

Since Specialization
Citations

This map shows the geographic impact of Jingfang Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingfang Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingfang Ju more than expected).

Fields of papers citing papers by Jingfang Ju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingfang Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingfang Ju. The network helps show where Jingfang Ju may publish in the future.

Co-authorship network of co-authors of Jingfang Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Jingfang Ju. A scholar is included among the top collaborators of Jingfang Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingfang Ju. Jingfang Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ju, Jingfang. (2025). Challenges and opportunities in microRNA-based cancer therapeutics. Cell Reports Medicine. 6(4). 102057–102057. 4 indexed citations
2.
3.
LaComb, Joseph F., et al.. (2023). 5-FU-miR-15a Inhibits Activation of Pancreatic Stellate Cells by Reducing YAP1 and BCL-2 Levels In Vitro. International Journal of Molecular Sciences. 24(4). 3954–3954. 7 indexed citations
4.
Ju, Jingfang, et al.. (2023). Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer. International Journal of Molecular Sciences. 24(24). 17523–17523. 10 indexed citations
5.
Hwang, Ga‐Ram, et al.. (2023). Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer. Molecular Therapy — Oncolytics. 28. 277–292. 5 indexed citations
6.
Zhou, Qi, Yuan Li, Lujun Chen, et al.. (2021). Long Non-Coding RNA GRIK1-AS1 Inhibits the Proliferation and Invasion of Gastric Cancer Cells by Regulating the miR-375/IFIT2 Axis. Frontiers in Oncology. 11. 754834–754834. 4 indexed citations
7.
Soung, Young Hwa, Heesung Chung, Andrew Fesler, et al.. (2020). Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers. Cancers. 12(8). 2209–2209. 8 indexed citations
8.
Su, Wenya, Lujun Chen, Qi Zhou, et al.. (2019). <p>Decreased IFIT2 Expression In Human Non-Small-Cell Lung Cancer Tissues Is Associated With Cancer Progression And Poor Survival Of The Patients</p>. OncoTargets and Therapy. Volume 12. 8139–8149. 12 indexed citations
9.
Ju, Jingfang, Wei Chen, Yunfeng Lai, et al.. (2017). Astragalus polysaccharides improve cardiomyopathy in STZ-induced diabetic mice and heterozygous (SOD2+/-) knockout mice. Brazilian Journal of Medical and Biological Research. 50(8). e6204–e6204. 11 indexed citations
10.
Yapici, Nazmiye, Yue Bi, Pengfei Li, et al.. (2015). Highly Stable and Sensitive Fluorescent Probes (LysoProbes) for Lysosomal Labeling and Tracking. Scientific Reports. 5(1). 8576–8576. 66 indexed citations
11.
Karaayvaz, Mihriban, et al.. (2012). Prognostic Significance of miR-205 in Endometrial Cancer. PLoS ONE. 7(4). e35158–e35158. 91 indexed citations
12.
Ju, Jingfang. (2012). Beyond Thymidylate Synthase and Dihydrofolate Reductase: Impact of Non-coding microRNAs in Anticancer Chemoresistance. Current Enzyme Inhibition. 8(2). 118–123. 7 indexed citations
13.
Guldvik, Ingrid Jenny, Rahul Palchaudhuri, Yaguang Xi, et al.. (2011). Triphenylmethyl Derivatives Enhances the Anticancer Effect of Immunotoxins. Journal of Immunotherapy. 34(5). 438–447. 14 indexed citations
14.
Kudo, Kenji, Yaguang Xi, Yuan Wang, et al.. (2010). Translational control analysis by translationally active RNA capture/microarray analysis (TrIP–Chip). Nucleic Acids Research. 38(9). e104–e104. 19 indexed citations
15.
Bruheim, Skjalg, Yaguang Xi, Jingfang Ju, & Øystein Fodstad. (2009). Gene Expression Profiles Classify Human Osteosarcoma Xenografts According to Sensitivity to Doxorubicin, Cisplatin, and Ifosfamide. Clinical Cancer Research. 15(23). 7161–7169. 33 indexed citations
16.
Mishra, Prasun, Bo Song, Pravin J. Mishra, et al.. (2009). MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism. PLoS ONE. 4(12). e8445–e8445. 91 indexed citations
17.
Song, Bo, Yuan Wang, Kenji Kudo, et al.. (2008). miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA Circuit. Clinical Cancer Research. 14(24). 8080–8086. 127 indexed citations
18.
19.
20.
Chu, Edward, Sitki Copur, Jingfang Ju, et al.. (1999). Thymidylate Synthase Protein and p53 mRNA Form an In Vivo Ribonucleoprotein Complex. Molecular and Cellular Biology. 19(2). 1582–1594. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinjun Li Breakdown of academic impact, for papers by Shijie Sheng Breakdown of academic impact, for papers by Kumaravel Somasundaram Breakdown of academic impact, for papers by Andreas G. Bader Breakdown of academic impact, for papers by David J. Wong Breakdown of academic impact, for papers by Ming Yao Breakdown of academic impact, for papers by Yang Wang Breakdown of academic impact, for papers by Fangyu Zhao Breakdown of academic impact, for papers by Yin‐Yuan Mo Breakdown of academic impact, for papers by Songqing Fan
Rankless by CCL
2026